Citation analysis for Drug Safety / Springer

Drug Safety / Springer

null

Impact Factor

null

5-Years IF

5-Years H index

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ]
[more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators

Raw data

	IF	AIF	IF5	DOC	CDO	CCU	CIF	CIT	D2Y	C2Y	D5Y	C5Y	%SC	CiY	II	AII
1990		0.1			0				0		0		(%)			0.04
1991		0.09			0				0		0		(%)			0.04
1992		0.1			0				0		0		(%)			0.04
1993		0.11			0				0		0		(%)			0.05
1994		0.12			0				0		0		(%)			0.05
1995		0.19			0				0		0		(%)			0.07
1996		0.22			0				0		0		(%)			0.09
1997		0.27			0				0		0		(%)			0.09
1998		0.27			0				0		0		(%)			0.1
1999		0.31			0				0		0		(%)			0.13
2000		0.4			0				0		0		(%)			0.15
2001		0.4			0				0		0		(%)			0.15
2002		0.42			0				0		0		(%)			0.18
2003		0.44			0				0		0		(%)			0.18
2004		0.49			0				0		0		(%)			0.2
2005		0.53			0				0		0		(%)			0.21
2006		0.51			0				0		0		(%)			0.2
2007		0.44			0				0		0		(%)			0.18
2008		0.47			0				0		0		(%)			0.2
2009		0.47			0				0		0		(%)			0.19
2010		0.44			0				0		0		(%)			0.16
2011		0.51			0				0		0		(%)			0.2
2012		0.56			0				0		0		(%)			0.21
2013		0.66			0				0		0		(%)			0.23
2014		0.67		8	8			1	0		0		1 (100%)			0.22
2015		0.82			8				8		8		(%)			0.27

IF:	Impact Factor: C2Y / D2Y
AIF:	Average Impact Factor for series in RePEc in year y
IF5:	Impact Factor: C5Y / D5Y
DOC:	Number of documents published in year y
CDO:	Cumulative number of documents published until year y
CCU:	Cumulative number of citations to papers published until year y
CIF:	Cumulative impact factor
CIT:	Number of citations to papers published in year y
D2Y:	Number of articles published in y-1 plus y-2
C2Y:	Cites in y to articles published in y-1 plus y-2
D5Y:	Number of articles published in y-1 until y-5
C5Y:	Cites in y to articles published in y-1 until y-5
%SC:	Percentage of selft citations in y to articles published in y-1 plus y-2
CiY:	Cites in year y to documents published in year y
II:	Immediacy Index: CiY / Documents.
AII:	Average Immediacy Index for series in RePEc in year y

50 most cited documents in this series:

#	Year	Title	Cited
1	2014	Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum. (2014). Lindquist, Marie ; Bate, Andrew ; Tuccori, Marco ; Hartigan-Go, Kenneth ; Beckmann, Jurgen ; McEwen, John ; Moride, Yola ; Wong, Ian ; Hagemann, Ulrich ; Boyd, Ian ; Olsson, Sten ; Edwards, I. ; Pal, Shanthi ; Pan, Gerald Dal ; Soulaymani-Bencheikh, Rachida ; Vaca, Claudia ; Bahri, Priya . In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:743-759. Full description at Econpapers \|\| Download paper	1
2	2016	Comment on âThe Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Projectâ. (2016). Braillon, Alain . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-016-0403-3. Full description at Econpapers \|\| Download paper	1
3	2016	The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project. (2016). Garbe, Edeltraut ; Pariente, Antoine ; Koci, Ariola ; Salvo, Francesco ; Moretti, Ugo ; Hazell, Lorna ; Perina, Luisella ; Ponti, Fabrizio ; Antoniazzi, Stefania ; Sturkenboom, Miriam ; Raschi, Emanuel ; Suling, Marc ; Poluzzi, Elisabetta . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:1:d:10.1007_s40264-015-0353-1. Full description at Econpapers \|\| Download Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases. (2016). Painter, Jeffery ; Slattery, Jim ; Noren, Niklas G ; Arani, Ramin ; Wisniewski, Antoni ; Quarcoo, Naashika ; Juhlin, Kristina ; Candore, Gianmario ; Seabroke, Suzie ; Tregunno, Philip . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0388-3. Full description at Econpapers \|\| Download paper	1
5	2016	An Empirical Approach to Explore the Relationship Between Measures of Disproportionate Reporting and Relative Risks from Analytical Studies. (2016). MacIa-Martinez, Miguel-Angel ; Roberts, Gilly ; Abajo, Francisco J ; Thakrar, Bharat ; Antoni, ; Slattery, Jim . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:1:d:10.1007_s40264-015-0351-3. Full description at Econpapers \|\| Download paper	1
6	2016	A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases. (2016). Tubert-Bitter, Pascale ; Robinson, Philip ; Salvo, Francesco ; Arnaud, Mickael ; Begaud, Bernard ; Moore, Nicholas ; Ahmed, Ismail ; Pariente, Antoine . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0375-8. Full description at Econpapers \|\| Download paper	1
7	2016	Comment on: âSafety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidenceâ. (2016). Braillon, Alain . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0447-4. Full description at Econpapers \|\| Download paper	1
8	2016	Drug Interactions of Direct-Acting Oral Anticoagulants. (2016). Fitzgerald, John Leonard ; Howes, Laurence Guy . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0443-8. Full description at Econpapers \|\| Download paper	1
9	2016	Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports. (2016). Klein, Kevin ; Puijenbroek, Eugene P ; Broekmans, Andre W ; Stolk, Pieter ; Bruin, Marie L ; Vermeer, Niels S. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:2:d:10.1007_s40264-015-0383-8. Full description at Econpapers \|\| Download paper	1
10	2016	Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?. (2016). Edwards, Ralph I ; Leufkens, Hubert ; Kant, Agnes ; Raine, June ; Harmark, Linda ; Moretti, Ugo ; Sarinic, Viola Macolic . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:10:d:10.1007_s40264-016-0441-x. Full description at Econpapers \|\| Download paper	1
11	2016	Measuring Signal Detection Performance: Can We Trust Negative Controls and Do We Need Them?. (2016). Slattery, Jim . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:5:d:10.1007_s40264-016-0407-z. Full description at Econpapers \|\| Download paper	1
12	2016	Reversal Strategies for NOACs: State of Development, Possible Clinical Applications and Future Perspectives. (2016). Comuth, Willemijn J ; Husted, Steen . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:1:d:10.1007_s40264-015-0357-x. Full description at Econpapers \|\| Download paper	1

50 most relevant documents in this series (papers most cited in the last two years)

#	Year	Title	Cited

Citing documents used to compute impact factor 0:

Year	Title

Recent citations (cites in year: CiY)

10 most frequent citing series

#		Series	Cites

Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.

Source data used to compute the impact factor of RePEc series.